Efficacy, safety, and pharmacokinetics study of Sifuvirtide for Injection in combination with HAART therapy in HIV infected subjects.
Phase of Trial: Phase II
Latest Information Update: 24 Apr 2016
At a glance
- Drugs Antiretrovirals; Sifuvirtide
- Indications HIV infections
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 21 May 2012 Planned end date (31 Dec 2009) added as reported by Chinese Clinical Trial Register.
- 01 Dec 2011 New trial record